|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 May 2001, Vol. 97, No. 10, pp. 2962-2971
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Comparison of outcomes of unrelated bone marrow and
umbilical cord blood transplants in children with acute
leukemia
Vanderson Rocha,
Jacqueline Cornish,
Eric L. Sievers,
Alexandra Filipovich,
Franco Locatelli,
Cristina Peters,
Mats Remberger,
Gérard Michel,
William Arcese,
Sandro Dallorso,
Karin Tiedemann,
Alessandro Busca,
Ka-Wah Chan,
Shunichi Kato,
Juan Ortega,
Marcus Vowels,
Axel Zander,
Gérard Souillet,
Anthony Oakill,
Ann Woolfrey,
Andrea L. Pay,
Ann Green,
Federico Garnier,
Irina Ionescu,
Peter Wernet,
Girolamo Sirchia,
Pablo Rubinstein,
Sylvie Chevret, and
Eliane Gluckman
From Eurocord Cord Blood Transplant Group (CBTG) and
Biostatistics Department, Saint Louis Hospital AP-HP, University of
Paris 7, France; Hospital for Sick Children, Bristol, United Kingdom;
Fred Hutchinson Cancer Research Center, Seattle, WA; Children's
Hospital Medical Center, Cincinnati, OH; Clinica Pediatrica, IRCCS
Policlinico San Matteo, Pavia, Italy; St Anna Kinderspital, Vienna,
Austria; Huddinge University Hospital, Huddinge, Sweden; Hospital La
Timone, Marseille, France; University La Sapienza, Rome, Italy;
Institute G. Gaslini, Genoa, Italy; Royal Children's Hospital,
Melbourne, Australia; Ospedale Regina Margherita, Turin, Italy; MD
Anderson Cancer Center, Houston, TX; Tokai University School of
Medicine, Isehara, Japan; Hospital Infantil Vall d'Hebron, Barcelona,
Spain; Sydney Children's Hospital, Sydney, Australia; University
Hospital Eppendorf, Hamburg, Germany; Hospital Debrousse, Lyon, France;
Anthony Nolan Bone Marrow Trust Registry, London, United Kingdom;
National Blood Service, Bristol, United Kingdom; Duesseldorf Cord Blood
Bank, Duesseldorf, Germany; Milano Cord Blood Bank, Milano, Italy; New
York Cord Blood Bank, New York, NY.
In order to compare the outcomes of unrelated umbilical cord blood
transplants (UCBTs) or bone marrow transplants, 541 children with acute leukemia (AL) transplanted with umbilical cord blood (n = 99), T-cell-depleted unrelated bone marrow transplants (T-UBMT) (n = 180), or nonmanipulated (UBMT) (n = 262), were analyzed in a
retrospective multicenter study. Comparisons were performed after
adjustment for patient, disease, and transplant variables. The
major difference between the 3 groups was the higher number in the UCBT
group of HLA mismatches (defined by serology for class I and molecular
typing for DRB1). The donor was HLA mismatched in 92% of UCBTs, in
18% of UBMTs, and in 43% of T-UBMTs (P < .001). Other
significant differences were observed in pretransplant disease characteristics, preparative regimens, graft-versus-host disease (GVHD)
prophylaxis, and number of cells infused. Nonadjusted estimates of
2-year survival and event-free survival rates were 49% and 43%,
respectively, in the UBMT group, 41% and 37% in the T-UBMT group, and
35% and 31% in the UCBT group. After adjustment, differences in outcomes appeared in the first 100 days after the transplantation. Compared with UBMT recipients, UCBT recipients had delayed
hematopoietic recovery (Hazard ratio [HR] = 0.37; 95% confidence
interval [95CI]: 0.27-0.52; P < .001), increased 100 day transplant-related mortality (HR = 2.13; 95CI: 1.20-3.76;
P < .01) and decreased acute graft-versus-host disease
(aGVHD) (HR = 0.50; 95CI: 0.34-0.73; P < .001). T-UBMT recipients had decreased aGVHD (HR = 0.25; 95CI: 0.17-0.36;
P < .0001) and increased risk of relapse (HR = 1.96;
95CI: 1.11-3.45; P = .02). After day 100 posttransplant,
the 3 groups achieved similar results in terms of relapse. Chronic GVHD
was decreased after T-UBMT (HR = 0.21; 95CI: 0.11-0.37;
P < .0001) and UCBT (HR = 0.24; 95CI: 0.01-0.66;
P = .002), and overall mortality was higher in T-UBMT
recipients (HR = 1.39; 95CI: 0.97-1.99; P < .07).
In conclusion, the use of UCBT, as a source of hematopoietic stem
cells, is a reasonable option for children with AL lacking an
acceptably matched unrelated marrow donor.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. R. Verneris, C. G. Brunstein, J. Barker, M. L. MacMillan, T. DeFor, D. H. McKenna, M. J. Burke, B. R. Blazar, J. S. Miller, P. B. McGlave, et al.
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units
Blood,
November 5, 2009;
114(19):
4293 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. KOBAYASHI, Y. MAEDA, Y. HARA, M. NISHIE-KATAOKA, H. NISHIMORI, H. SUGIYAMA, N. NAMBA, S. KUBONISHI, M. NIIYA, K. SHINAGAWA, et al.
Clinical Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation for 30 Adults with Hematological Malignancies
Anticancer Res,
May 1, 2009;
29(5):
1763 - 1770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gluckman and V. Rocha
Cord blood transplantation: state of the art
Haematologica,
April 1, 2009;
94(4):
451 - 454.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G N Samuel, K A Strong, I Kerridge, C F C Jordens, R A Ankeny, and P J Shaw
Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do "saviour siblings" have in paediatric transplantation?
Arch. Dis. Child.,
April 1, 2009;
94(4):
317 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. MacMillan, D. J. Weisdorf, C. G. Brunstein, Q. Cao, T. E. DeFor, M. R. Verneris, B. R. Blazar, and J. E. Wagner
Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors
Blood,
March 12, 2009;
113(11):
2410 - 2415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Atsuta, R. Suzuki, T. Nagamura-Inoue, S. Taniguchi, S. Takahashi, S. Kai, H. Sakamaki, Y. Kouzai, M. Kasai, T. Fukuda, et al.
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
Blood,
February 19, 2009;
113(8):
1631 - 1638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Morra, G. Barosi, A. Bosi, F. Ferrara, F. Locatelli, M. Marchetti, G. Martinelli, C. Mecucci, M. Vignetti, and S. Tura
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation
Haematologica,
January 1, 2009;
94(1):
102 - 112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lisini, M. Zecca, G. Giorgiani, D. Montagna, R. Cristantielli, M. Labirio, P. Grignani, C. Previdere, A. Di Cesare-Merlone, G. Amendola, et al.
Donor/recipient mixed chimerism does not predict graft failure in children with {beta}-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling
Haematologica,
December 1, 2008;
93(12):
1859 - 1867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kurtzberg, V. K. Prasad, S. L. Carter, J. E. Wagner, L. A. Baxter-Lowe, D. Wall, N. Kapoor, E. C. Guinan, S. A. Feig, E. L. Wagner, et al.
Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies
Blood,
November 15, 2008;
112(10):
4318 - 4327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Prasad, A. Mendizabal, S. H. Parikh, P. Szabolcs, T. A. Driscoll, K. Page, S. Lakshminarayanan, J. Allison, S. Wood, D. Semmel, et al.
Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes
Blood,
October 1, 2008;
112(7):
2979 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Iori, W. Arcese, F. Milano, E. Calabrese, G. F. Torelli, W. Barberi, M. G. Mascolo, L. De Felice, M. Screnci, B. Lucarelli, et al.
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up
Haematologica,
August 1, 2007;
92(8):
1051 - 1058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Fujii, J. D. Trudeau, D. T. Teachey, J. D. Fish, S. A. Grupp, K. R. Schultz, and G. S. D. Reid
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
Blood,
March 1, 2007;
109(5):
2008 - 2013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Section on Hematology/Oncology and Section on Alle
Cord Blood Banking for Potential Future Transplantation
Pediatrics,
January 1, 2007;
119(1):
165 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Eapen, P. Rubinstein, M.-J. Zhang, B. M. Camitta, C. Stevens, M. S. Cairo, S. M. Davies, J. J. Doyle, J. Kurtzberg, M. A. Pulsipher, et al.
Comparable Long-Term Survival After Unrelated and HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantations for Acute Leukemia in Children Younger Than 18 Months
J. Clin. Oncol.,
January 1, 2006;
24(1):
145 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Ballen
New trends in umbilical cord blood transplantation
Blood,
May 15, 2005;
105(10):
3786 - 3792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Katsumoto, J. Duda, A. Kim, Z. Wardak, G. Dranoff, D. W. Clapp, and K. Shannon
Granulocyte/macrophage colony-stimulating factor and accessory cells modulate radioprotection by purified hematopoietic cells
J. Exp. Med.,
March 21, 2005;
201(6):
853 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Barker, D. J. Weisdorf, T. E. DeFor, B. R. Blazar, P. B. McGlave, J. S. Miller, C. M. Verfaillie, and J. E. Wagner
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy
Blood,
February 1, 2005;
105(3):
1343 - 1347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hidalgo and P. S. Frenette
Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow
Blood,
January 15, 2005;
105(2):
567 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Locatelli, P. Nollke, M. Zecca, E. Korthof, E. Lanino, C. Peters, A. Pession, H. Kabisch, C. Uderzo, C. S. Bonfim, et al.
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial
Blood,
January 1, 2005;
105(1):
410 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Takahashi, T. Iseki, J. Ooi, A. Tomonari, K. Takasugi, Y. Shimohakamada, T. Yamada, K. Uchimaru, A. Tojo, N. Shirafuji, et al.
Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies
Blood,
December 1, 2004;
104(12):
3813 - 3820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Laughlin, M. Eapen, P. Rubinstein, J. E. Wagner, M.-J. Zhang, R. E. Champlin, C. Stevens, J. N. Barker, R. P. Gale, H. M. Lazarus, et al.
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
N. Engl. J. Med.,
November 25, 2004;
351(22):
2265 - 2275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rocha, M. Labopin, G. Sanz, W. Arcese, R. Schwerdtfeger, A. Bosi, N. Jacobsen, T. Ruutu, M. de Lima, J. Finke, et al.
Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia
N. Engl. J. Med.,
November 25, 2004;
351(22):
2276 - 2285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Sanz
Cord-Blood Transplantation in Patients with Leukemia -- A Real Alternative for Adults
N. Engl. J. Med.,
November 25, 2004;
351(22):
2328 - 2330.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Xia, J. M. McDaniel, T. Yago, A. Doeden, and R. P. McEver
Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow
Blood,
November 15, 2004;
104(10):
3091 - 3096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Flomenberg, L. A. Baxter-Lowe, D. Confer, M. Fernandez-Vina, A. Filipovich, M. Horowitz, C. Hurley, C. Kollman, C. Anasetti, H. Noreen, et al.
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome
Blood,
October 1, 2004;
104(7):
1923 - 1930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fujisaki, M. Kami, Y. Kishi, S. L. Staba, and J. Kurtzberg
Cord-Blood Transplants from Unrelated Donors in Hurler's Syndrome
N. Engl. J. Med.,
July 29, 2004;
351(5):
506 - 507.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Miyakoshi, K. Yuji, M. Kami, E. Kusumi, Y. Kishi, K. Kobayashi, N. Murashige, T. Hamaki, S.-W. Kim, J.-i. Ueyama, et al.
Successful Engraftment After Reduced-Intensity Umbilical Cord Blood Transplantation for Adult Patients with Advanced Hematological Diseases
Clin. Cancer Res.,
June 1, 2004;
10(11):
3586 - 3592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Montagna, F. Locatelli, A. Moretta, D. Lisini, C. Previdere, P. Grignani, P. DeStefano, G. Giorgiani, E. Montini, S. Pagani, et al.
T lymphocytes of recipient origin may contribute to the recovery of specific immune response toward viruses and fungi in children undergoing cord blood transplantation
Blood,
June 1, 2004;
103(11):
4322 - 4329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jiang, C. Van de Ven, P. Satwani, L. V. Baxi, and M. S. Cairo
Differential Gene Expression Patterns by Oligonucleotide Microarray of Basal versus Lipopolysaccharide-Activated Monocytes from Cord Blood versus Adult Peripheral Blood
J. Immunol.,
May 15, 2004;
172(10):
5870 - 5879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ooi, T. Iseki, S. Takahashi, A. Tomonari, K. Takasugi, Y. Shimohakamada, T. Yamada, K. Ishii, N. Ohno, F. Nagamura, et al.
Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia
Blood,
January 15, 2004;
103(2):
489 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Chao, S. G. Emerson, and K. I. Weinberg
Stem Cell Transplantation (Cord Blood Transplants)
Hematology,
January 1, 2004;
2004(1):
354 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Michel, V. Rocha, S. Chevret, W. Arcese, K.-W. Chan, A. Filipovich, T. A. Takahashi, M. Vowels, J. Ortega, P. Bordigoni, et al.
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis
Blood,
December 15, 2003;
102(13):
4290 - 4297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cookson and D. Reen
IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells
Blood,
September 15, 2003;
102(6):
2195 - 2197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Barker, D. J. Weisdorf, T. E. DeFor, B. R. Blazar, J. S. Miller, and J. E. Wagner
Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning
Blood,
September 1, 2003;
102(5):
1915 - 1919.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Frassoni, M. Podesta, R. Maccario, G. Giorgiani, G. Rossi, M. Zecca, A. Bacigalupo, G. Piaggio, and F. Locatelli
Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation
Blood,
August 1, 2003;
102(3):
1138 - 1141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Grewal, J. N. Barker, S. M. Davies, and J. E. Wagner
Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?
Blood,
June 1, 2003;
101(11):
4233 - 4244.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Reed, R. Smith, F. Dekovic, J. Y. Lee, J. D. Saba, E. Trachtenberg, J. Epstein, S. Haaz, M. C. Walters, and B. H. Lubin
Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease
Blood,
January 1, 2003;
101(1):
351 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Wagner, J. N. Barker, T. E. DeFor, K. S. Baker, B. R. Blazar, C. Eide, A. Goldman, J. Kersey, W. Krivit, M. L. MacMillan, et al.
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
Blood,
August 13, 2002;
100(5):
1611 - 1618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Woolfrey, C. Anasetti, B. Storer, K. Doney, L. A. Milner, E. L. Sievers, P. Carpenter, P. Martin, E. Petersdorf, F. R. Appelbaum, et al.
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
Blood,
March 15, 2002;
99(6):
2002 - 2008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Drobyski, J. Klein, N. Flomenberg, D. Pietryga, D. H. Vesole, D. A. Margolis, and C. A. Keever-Taylor
Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen- disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts
Blood,
February 1, 2002;
99(3):
806 - 814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hoelzer, N. Gokbuget, O. Ottmann, C.-H. Pui, M. V. Relling, F. R. Appelbaum, J. J.M. van Dongen, and T. Szczepanski
Acute Lymphoblastic Leukemia
Hematology,
January 1, 2002;
2002(1):
162 - 192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Sanz, S. Saavedra, D. Planelles, L. Senent, J. Cervera, E. Barragan, C. Jimenez, L. Larrea, G. Martin, J. Martinez, et al.
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies
Blood,
October 15, 2001;
98(8):
2332 - 2338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gluckman
Hematopoietic Stem-Cell Transplants Using Umbilical-Cord Blood
N. Engl. J. Med.,
June 14, 2001;
344(24):
1860 - 1861.
[Full Text]
[PDF]
|
 |
|
|
|